Literature DB >> 17179239

ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).

Lee A Fleisher, Joshua A Beckman, Kenneth A Brown, Hugh Calkins, Elliott L Chaikof, Kirsten E Fleischmann, William K Freeman, James B Froehlich, Edward K Kasper, Judy R Kersten, Barbara Riegel, John F Robb.   

Abstract

The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines makes every effort to avoid any actual, potential, or perceived conflict of interest that might arise as a result of an industry relationship or personal interest of the writing committee. Specifically, all members of the writing committee, as well as peer reviewers of the document, were asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing committee at each meeting, and updated and reviewed by the writing committee as changes occur. Please see Appendix 1 for author relationships with industry and Appendix 2 for peer reviewer relationships with industry. These guidelines attempt to define practices that meet the needs of most patients in most circumstances. These guideline recommendations reflect a consensus of expert opinion after a thorough review of the available, current scientific evidence and are intended to improve patient care. If these guidelines are used as the basis for regulatory/payer decisions, the ultimate goal is quality of care and serving the patient's best interests. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and patient in light of all the circumstances presented by that patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17179239     DOI: 10.1213/01.ane.0000243335.31748.22

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

Review 1.  Drugs for the perioperative control of hypertension: current issues and future directions.

Authors:  Robert Feneck
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Low-dose landiolol for hypertension with tachycardia following neurosurgery.

Authors:  Masamitsu Sanui; Koichi Matsuo; Hiroshi Sunagawa
Journal:  J Anesth       Date:  2008-05-25       Impact factor: 2.078

Review 3.  Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.

Authors:  Zui Zou; Hong B Yuan; Bo Yang; Fengying Xu; Xiao Y Chen; Guan J Liu; Xue Y Shi
Journal:  Cochrane Database Syst Rev       Date:  2016-01-27

4.  Cardiac overscreening hip fracture patients.

Authors:  S J M Smeets; B P W van Wunnik; M Poeze; G D Slooter; J P A M Verbruggen
Journal:  Arch Orthop Trauma Surg       Date:  2019-08-31       Impact factor: 3.067

5.  Pedunculopontine Nucleus Dysconnectivity Correlates With Gait Impairment in Parkinson's Disease: An Exploratory Study.

Authors:  Stephen Joza; Richard Camicioli; W R Wayne Martin; Marguerite Wieler; Myrlene Gee; Fang Ba
Journal:  Front Aging Neurosci       Date:  2022-07-08       Impact factor: 5.702

6.  Operative debridement of pressure ulcers.

Authors:  Jessica Schiffman; Michael S Golinko; Alan Yan; Anna Flattau; Marjana Tomic-Canic; Harold Brem
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.